Method genetically defines patients who would benefit from intensifying the chemotherapy, adding a new drug, or having chemotherapy reduced to avoid toxicity.
Implications of using beneficial cardiovascular precision medicine-based screening approaches to raise awareness in at-risk populations
De-identified data that hospitals and health systems share with big tech can sometimes be used to identify patients. As these types of deals grow, full transparency with patients is key…
While a recent report suggests expanding or initiating precision medicine efforts is imminent among health systems, some worry that precision medicine may take away from population health. The task for hospital and health system leaders is to determine a complementing balance of both efforts A report from the Center for Connected Medicine demonstrates just how
The need to build up critical mass quickly may tempt hospital and health system leaders to cut corners when it comes to being forthcoming with patients. Don’t fall into that trap…
Considering a Precision Medicine Data Storage Partnership? Beware of Privacy Pitfalls Read More »
Effective communication with providers and patients can bridge the gap that exists between precision medicine’s benefits and wider patient access…
The Good News and Bad News About Where Precision Medicine Stands in 2020 Read More »
With precision medicine gaining momentum as a guiding approach to healthcare practice and treatments, early pharmacogenomic testing in the consumer market is laying some of the foundation for use in psychiatry…
Clinicians Looking for Guidance on Pharmacogenomic Testing in Psychiatry Read More »
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions…
Analysts predict that the global tissue banking market will grow to nearly $3 billion by 2026. Health executives at UCSF have recognized this trend and are executing on plan to attract patients and funding, and ultimately improve outcomes…
UCSF Steps Up Biobanking Program Efforts, Naming Its First Chief Biobank Officer Read More »
Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…
Pharmacogenomics to Eventually Touch Every Patient, Everywhere, Expert Says Read More »
